Compare Nusantara Pelabuhan Handal Tbk. (PORT) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nusantara Pelabuhan Handal Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Nusantara Pelabuhan Handal Tbk. trades at Rp950 (market cap 2.57T, 42K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Nusantara Pelabuhan Handal Tbk. is far larger — about 24.6× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| PORT | SCPI | |
|---|---|---|
Market Cap | 2.57T | 104.4B |
Volume | 42K | — |
Lot | 420 | — |
Turnover | 39.75M | — |
Average Price | 946.45 | — |
Value | 39.75M | — |
Indicative Equilibrium Price | 940 | — |
Indicative Equilibrium Volume | 3 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nusantara Pelabuhan Handal Tbk.
PT Nusantara Pelabuhan Handal Tbk (formerly PT Kharisma Mutiara Agung) (the Company) was established dated December 29, 2003 in accordance with Notarial Deed No. 8 of Periasman Effendi, S.H. PT Episenta Utama Investasi is the Company's parent entity which is indirectly controlled by Garibaldi Thohir.
Read more on PORT →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
